Public Advisories

January 15, 2010

Apo-Levocarb CR 200/50

The product Apo-Levocarb CR 200/50 has been temporarily discontinued. Apotex Inc, is continuing efforts to ensure product is made available to Canadian patients as soon as possible. Should you have any concerns please contact your physician.

October 2009

Apo-Lithium Carbonate SR

Apotex Inc., in collaboration with Health Canada, wishes to advise health care professionals that a recall of Apo-Lithium Carbonate SR 300 mg strength tablets was initiated on 20 October 2009 due to stability issues which may have had an impact on the quality of the product.

July 2008

Apo-Desmopressin

Desmopressin nasal sprays, (including Apo-Desmopressin Spray), are associated with an increased risk of serious side effects involving water retention and decreased blood sodium levels (hyponatremia).

January 2005

Apo-Mefloquine

Important safety information for patients taking Apo-Mefloquine (mefloquine) for the prevention of malaria.